Abstract:Over the last decade, microglia have been acknowledged to be key players in central nervous system (CNS) under both physiological and pathological conditions. They constantly survey the CNS environment and as immune cells, in pathological contexts, they provide the first host defense and orchestrate the immune response. It is well recognized that under pathological conditions microglia have both sequential and simultaneous, beneficial and detrimental effects. Cell-specific transcriptomics recently became popular in Neuroscience field allowing concurrent monitoring of the expression of numerous genes in a given cell population. Moreover, by comparing two or more conditions, these approaches permit to unbiasedly identify deregulated genes and pathways. A growing number of studies have thus investigated microglial transcriptome remodeling over the course of neuropathological conditions and highlighted the molecular diversity of microglial response to different diseases. In the present work, we restrict our review to microglia obtained directly from in vivo samples and not cell culture, and to studies using whole-genome strategies. We first critically review the different methods developed to decipher microglia transcriptome. In particular, we compare advantages and drawbacks of flow cytometry and laser microdissection to isolate pure microglia population as well as identification of deregulated microglial genes obtained via RNA sequencing (RNA-Seq) vs. microarrays approaches. Second, we summarize insights obtained from microglia transcriptomes in traumatic brain and spinal cord injuries, pain and more chronic neurological conditions including Amyotrophic lateral sclerosis (ALS), Alzheimer disease (AD) and Multiple sclerosis (MS). Transcriptomic responses of microglia in other non-neurodegenerative CNS disorders such as gliomas and sepsis are also addressed. Third, we present a comparison of the most activated pathways in each neuropathological condition using Gene ontology (GO) classification and highlight the diversity of microglia response to insults focusing on their pro- and anti-inflammatory signatures. Finally, we discuss the potential of the latest technological advances, in particular, single cell RNA-Seq to unravel the individual microglial response diversity in neuropathological contexts.

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

Microglia: a sensor for pathological events in the CNS

Microglia pack a toolbox for life

Microglia: a sensor to threats in the nervous system?

Microglia: Housekeeper of the Central Nervous System

Microglia--performers of the 21st century

Microglia--friend or Foe.

The ins and outs of microglial cells in brain health and disease

Microglia and macrophages in brain homeostasis and disease

Microglia Reactivity: Heterogeneous Pathological Phenotypes

Microglia in Health and Diseases: Integrative Hubs of the Central Nervous System (CNS)

Functions of microglia in the central nervous system--beyond the immune response

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

General Pathophysiology of Microglia

Microglia: Activity‐dependent regulators of neural circuits

The microglia in healthy and diseased retina

Microglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities

Microglial metabolic flexibility supports immune surveillance of the brain parenchyma

The Changing Phenotype of Microglia from Homeostasis to Disease.

Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us

What Is the Role of Microglial Metabolism in Inflammation and Neurodegeneration?